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Abstract
Based on the analysis of the drafts of the human genome sequence, it is being speculated
that our species may possess an unexpectedly low number of genes. The quality of the
drafts, the impossibility of accurate gene prediction and the lack of sufﬁcient transcript
sequence data, however, render such speculations very premature. The complexity of
human gene structure requires additional and extensive experimental veriﬁcation of
transcripts that may result in major revisions of these early estimates of the number
of human genes. Copyright # 2001 John Wiley & Sons, Ltd.
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Introduction
Of all the justiﬁcations to sequence the human
genome, the identiﬁcation of the complete set of
human genes is probably the most compelling.
Certainly, it is the gene content, which is the facet
of the genome, that is of the widest interest to both
academic scientists and corporate research organi-
zations alike. In this regard, there have been strong
statements made about the gene content of the
human genome, particularly in the press, following
the completion of the draft human genome
sequence. The general trend has been to draw
attention to the conclusion that the human
genome contains a surprisingly small number of
genes that is not signiﬁcantly removed from the
number of genes present in the genome of lower
eukaryotes that have been sequenced. The pub-
lished manuscripts [18,29] describing this milestone
in the evolution of science are somewhat more
cautious, however, and the truth is that at the
present time we have no real idea of the number of
human genes, let alone what they encode and how
they function. It is ironic that the essential comple-
tion of the human genome sequencing with the
enormous investments of time and money that this
has entailed, has not led to the most eagerly awaited
portion of the information that it contains, the
identiﬁcation of human genes. The reason for this is
that, although the human genome sequence is
essential for the accurate description and cataloging
of human genes, it is not sufﬁcient. Human genes
are highly complex structures and as yet we are not
able to predict their presence with any certainty by
inspection of genomic DNA sequence. Rather this
absolutely requires direct experimental evidence in
the form of transcript sequencing.
Identiﬁcation of genes within prokaryotic
and eukaryotic genome sequences
The paradigm of whole genome sequencing as a
route to determine gene complement has proved
robust in the context of prokaryotic organisms [6,12].
Bacterial genomes are highly compact suggesting a
strong selective pressure to reduce genome size.
Thus, genes are head to tail with one another and,
crucially for gene hunters, uninterrupted by introns.
Thus the standard procedure for gene identiﬁcation,
is to ﬁrst identify open reading frames with an
algorithm such as Glimmer [8]. Subsequently these
ORFs are annotated, or assigned putative function,
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proteins from other organisms using programs such
as BLAST [2].
Even for bacterial genomes this is not fool-proof,
however, as an arbitrary lower limit to the size of
ORFs taken as real has to be imposed close to those
that can be expected to occur by chance within non-
coding DNA sequences. This is a serious limitation
in the absence of any similarity between the
putative ORF and known genes and proteins.
Nevertheless, the identiﬁcation of approximately
one gene per kb of genome sequence has been
possible for all bacteria for which the genome
sequence is publicly available. The conﬁdence level
is high due to the combined evidence of long open
reading frames and similarity with previously
deﬁned genes. Thus, although there may be some
error in the precise deﬁnition of the initiation
codon, in general there is no need for further
conﬁrmation of gene structure by transcript sequen-
cing or microarray experimentation. In addition, it
should be remembered that this kind of gene
identiﬁcation is based on complete, high quality
sequences that contain no gaps and where all
ambiguities have been resolved.
There are two fundamental differences between
prokaryotic and eukaryotic gene structure that
complicate the identiﬁcation of eukaryotic genes
within genome sequence. The ﬁrst is that the rela-
tive proportion of the genome occupied by genes is
considerably smaller in eukaryotes. Although there
is approximately one gene per kb in bacterial
genomes, there is only about one per 100 kb in the
human genome [18,29]. Thus we are dealing with a
structure where the genes are two orders of magni-
tude more widely spread. Far more importantly,
however, is that eukaryotic genes are fragmented
into exons separated by intervening introns. Thus
the ﬁrst step in gene identiﬁcation, that of putative
ORF detection, is not possible in the context of the
human genome. This is the fundamental problem of
human gene identiﬁcation based on genomic
sequence alone. Indeed, this problem is more acute
in the human genome than in the other eukaryotic
genomes sequenced due to the signiﬁcantly greater
sizes of human introns [18,29].
By aligning previously sequenced, complete
cDNAs with human genomic sequence the general
characteristics of human gene structure have been
outlined. The comparison of these data with other
eukaryotic genomes shows that the average overall
length of coding regions in C. elegans (the worm),
D. melanogaster (the ﬂy) and for H. sapiens
(human) is 1311, 1497 and 1340 bp respectively
[18]. In addition, it reveals that in all three
organisms internal exons are generally between 50
and 200 bp with the average exon sizes for the
worm and for human being 218 bp and 147 bp
respectively. On the other hand, intron sizes are
found to be signiﬁcantly larger in human. In the
worm and the ﬂy the averages are 267 bp and
487 bp respectively while in human the average is
roughly ten times greater, 3300 bp [18]. Moreover,
the variation in intron size is markedly greater in
human. This highly dispersed and variable nature of
human genes makes them simply impossible to
detect with any accuracy by simple inspection of the
human genome, even aided by the most sophisti-
cated algorithms produced to date. Thus, when all
is said and done, the sequencing of the human
genome did not lead to gene identiﬁcation, as was
the expectation. Genes previously deﬁned by cDNA
sequencing could be aligned to the genome, allow-
ing their precise mapping and the deﬁnition of
intron-exon structure, but no new genes could be
identiﬁed from genome sequence alone.
Gene identiﬁcation in the human
genome drafts
Although gene discovery did not feature in the
completion of the draft genome sequence, both the
International Human Genome Sequencing Consor-
tium (IHGSC) and Celera projects catalogued the
position of those genes that are already well deﬁned
by comparison of high quality, full-length mRNA
sequences with the draft genome [18,29]. This
allowed the intron-exon boundaries of the corre-
sponding genes to be deﬁned for the ﬁst time in
many cases. Importantly, however, this exercise also
permitted the suitability of the draft genome for
novel gene identiﬁcation to be assessed.
In both projects the RefSeq database [22] was
used as the source of high quality full-length
transcript sequences. RefSeq is a carefully, manu-
ally curated, non-redundant data set that contains
most genes for which a reliable full-length mRNA
sequence is available [22]. At the time of the genome
annotation, RefSeq contained 10 271 human
mRNAs. When these were compared to the
IHGSC draft it was found that of the RefSeq
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over at least some portion of their length, 85%
could be aligned over at least half of their length
but in only 52% could an essentially complete
alignment be achieved [18]. Thus almost half of
known genes were only found to be partially
represented in the genome sequence demonstrating
the rudimentary nature of the draft genome
sequence and hence its lack of present suitability
as a basis for novel gene identiﬁcation.
Even if it were possible to accurately predict
genes based on sequence data alone, the draft at the
time of publication is arguably simply too frag-
mented to make this a worthwhile exercise. Indeed,
on examining the largest 10 genes in Ref Seq, Aach
et al., found that only six had both ends in the same
contig of the human genome assembly, two genes
had ends in different contigs and the remaining two
had only one end that could be found within the
genome sequence [1].
In the case of the Celera [29] sequence it was
possible to identify only 6538 of the genes corre-
sponding to the RefSeq sequences on the basis of a
match against the genome for at least 50% of their
length with >92% identity. Again, this rather small
number reveals the extent of fragmentation and
error in the sequence and the difﬁculty therefore of
using it for novel gene prediction.
Thus in both cases we have to take the highly
fragmentednatureofthedraftsequencesintoaccount
when assessing estimates of gene numbers. Clearly
over the coming months an essentially ﬁnished
sequence will become available that will circumvent
this problem. The question then remains as to how
to identify genes in this high quality sequence.
Human gene prediction
Despite the shortcomings of the draft sequence as a
source for gene discovery, efforts were made by the
IHGSC in this direction by building what they term
an initial gene index (IGI) [18]. This was produced
ﬁrstly by using the Ensembl system that involves a
prediction program together with conﬁrmatory
evidence from ESTs, proteins, protein motifs and
sequences from other organisms. In addition, a
second approach was taken whereby attempts were
made to extend EST and mRNA matches using
statistical approaches. As a result of these studies a
total of 31 778 protein predictions were made of
which 14 882 represented known genes [18].
The limitations of this approach were assessed by
comparison with newly discovered genes arising
from independent work that were not used in the
gene prediction effort. Of 31 such genes, only 19
(68%) were represented in the predictions. Further-
more, of each gene predicted an average of 79% was
detected [18]. In a less direct, but larger scale
approach a set of 15 294 full-length mouse cDNAs
was examined and again only 69% showed any
similarity with the predicted human genes [17,18].
Moreover, of 817 mouse hypothetical transcripts
for which there were no corresponding human
genes in RefSeq, Human Unigene or Ensemble
database, only 174 perfectly matched GenScan
predictions and 322 sequences did not hit any
exons predicted by GenScan. The remaining 311
showed partial matches because GenScan did not
predict one or more exons [17]. Although detailed
calculations of sensitivity, fragmentation and pre-
diction rates are tempting, the best conclusion is
that these approaches are so inexact that there is
little point in extrapolating from such theoretical
exercises to the number, structure or function of
human genes.
A combination of predictions and comparisons
with proven transcripts were also utilized in order
to identify human genes within the Celera draft [29].
In addition to the genes identiﬁed on the basis of
RefSeq comparisons, a further 11 226 genes were
predicted using a novel system named ‘Otto’ that
attempts to reproduce in an automated way the
kind of assessment of transcript evidence that a
human annotator undertakes. In addition, 8619
genes detected on the basis of at least two
conﬁrmatory lines of evidence (ESTs, protein,
mouse genome matches) for separate de novo gene
predictions. This latter number increased to 21 350
if only one line of conﬁrmatory evidence was taken
as sufﬁcient [29]. Thus the overall numbers that
result from this analysis are very similar to those
obtained from the IHGSC project [18]. Although,
the kind of detailed assessment of the limitations of
the predictions provided in the IHGSC paper was
not presented, the numbers provided suggest that a
similar level of accuracy and completeness is
probable. Indeed, in this regard the data of Aach
et al. conclude that the quality of the two draft
sequences are of a similar quality as judged by
sequence gaps, continuity, consistency between the
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tein motifs [1].
Both studies leave us at a very preliminary stage
as judged by the similarity of the numbers of genes
found and the detailed assessment of the lack of
accuracy of the methodology utilized as detailed in
the case of the IHGSC manuscript. This lack of
precision of prediction of human genes has been
amply documented elsewhere and the data in the
genome papers are entirely consistent with the
overall position of this ﬁeld [5,13].
Estimates of the number of human
genes
The ﬁnal overall estimates of the number of genes
in the human genome are 30–40 000 in the case of
the IHGSC and 26–38 000 in the case of Celera
[18,29]. These estimates were made despite the
shortcomings outlined above. This does not mean
that the estimates are wrong only that it is too early
to be sure. They are consistent with extrapolations
of gene numbers from the published chromosome
21 and 22 sequences [10,14]. In addition, the human
genome papers quote recent independent estimates
as supporting evidence for these low numbers. One
of these papers involves the calculation of the gene
number by comparing the number of known genes
and ESTs and arrives at estimates of approximately
34 000 [11]. The known genes used were those
for which we have a full-length mRNA or those
annotated on chromosome 22. The estimate
depends on these sets being representative of all
genes particularly in terms of expression level. At
least in terms of the full-length mRNAs this is
clearly not the case and thus the assessment may be
ﬂawed. For example, if we take Unigene cluster size
as a rough estimate of expression level, we can ﬁnd
38 789 clusters in Unigene Build 128 composed of
two to 10 sequences (representing rarely expressed
genes) of which 1985 (5.1%) contain a full-length
cDNAs whereas there are 4572 clusters of 100 or
more sequences (representing highly expressed
genes) of which 4249 (92.9%) contain a full-length
cDNA (unpublished observations).
The other paper involves comparison between
human and Tetraodon nigroviridis (a pufferﬁsh)
DNA as the basis of exon identiﬁcation [7]. This
estimate arrives at the similar number of 28–34 000
genes. Again, however, this estimate crucially relies
on the relatedness of the fully characterized human
genesandpufferﬁshsequencesreﬂectingthatoftheyet
tobedeﬁnedhumangenesandpufferﬁshsequences. It
should be noted that a companion paper of those
cited above that simply depended on the very
careful clustering of available EST sequences came
to the conclusion that there are in the range of
120 000 human genes [21]. This paper did not have
the beneﬁt of the human genome sequence to aid
clustering and may certainly have overestimated
gene number due to the complexity of alternative
splicing and polyadenylation. Nevertheless, it serves
to show how essentially the same data can lead to
very different conclusions when analyzed in differ-
ent ways using different assumptions.
The need for further transcript
sequencing
In the closing sections of their paper the Celera
team admit: ‘As was true at the beginning of
genome sequencing, ultimately it will be necessary
to measure mRNA in speciﬁc cell types to demon-
strate the presence of a gene’ [29]. We whole-
heartedly agree with this statement. A pervasive
view is that the sequencing of the genome of other
species may also be a strategy for gene identiﬁcation
[3,7]. Certainly, comparison with organisms at an
appropriate evolutionary distance is a valuable way
of identifying probable genes. The more genomes
there are to compare the better such predictions will
be. We believe, however, that this will never
substitute for transcript sequencing due to the
difﬁculty in identifying the exact start and stop of
each exon not to mention the added value of
alternative splicing and expression patterns that
transcript sequencing provides.
That is not to say that transcript sequencing is
not without its shortcomings. Firstly, it is clear that
the amount of transcript data that will be required
to ﬁnd all human genes will be enormous. At the
time of the annotation of the draft human
sequences, around 10 000 putative full-length
sequences were available and in the order of 3-
million ESTs. This was clearly woefully deﬁcient
given the huge uncertainties in ﬁnding human genes
that are alluded to above. It may ultimately be
necessary to obtain the full sequence at least one
example of every transcript in every cell type and all
developmental stages to identify all genes (the
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requirements are circumvented). In addition, it will
be necessary to cover each gene several times in
different tissues in order to identify splicing alter-
natives that are often tissue speciﬁc. One approach
to this multiple coverage is to adopt a high-
throughput approach to transcript sequencing in a
shotgun like format. This can now be effectively
achieved using a combination of 3k and 5k EST
sequencing together with our own Open Reading
Frame EST (ORESTES) approach that tags the
central portions of transcripts [9]. ORESTES is also
a more realistic approach for searching for rare,
tissue speciﬁc transcripts. The ORESTES method-
ology strongly normalizes and uses only minimal
amounts of mRNA permitting such surveying to
be contemplated. One could contemplate using
ORESTES to provide the initial evidence of a
transcript followed by a planned experimental
strategy such as cDNA library screening or RACE
to ﬁnd the rest of the transcript. Alternative splices
could then be sought by RT-PCR analyses.
The other principle problem with transcript
sequencing is its technical difﬁculty that is signiﬁ-
cantly greater than that of genome sequencing
particularly in relation to template preparation. In
this regard trace amounts of genomic DNA are
often incorporated into both ORESTES and con-
ventional ESTs. Thus, careful analysis has to be
undertaken and conﬁrmatory evidence such as the
presence of a splice site or the generation of the
same putative transcript fragment from distinct
libraries always sought.
We take the view that a combination of exhaus-
tive transcript sequencing together with the avail-
ability of a high quality genome sequence is an
absolute requirement of the compilation of a
meaningful human gene catalogue. The ﬁrst steps
in this direction are now possible by careful and
complete cross-analysis between the transcript and
genomic sequence data. Such mapping exercises
give an idea of the complexity of the situation and
the necessity of an extensive investment in further
experimental analysis. Figure 1 shows an example
of where we have mapped all available transcript
data to a region of the X-chromosome. The
example shows three regions of clustered ESTs.
We suspect that those in the middle comprise a gene
since a putative full-length sequence has been
generated. Such sequences have not been generated
for the other two clusters however. At the present
moment, based on careful analysis of the 3k-
sequences and the likelihood that they represent
authentic poly-A tails we predict that the left hand
cluster corresponds to a single gene while that on
the right actually represents two distinct, but closely
positioned, genes.
Further in relation to the complexity of the
relationship between transcript structure and
genome sequence several situations well documen-
ted in the literature are pertinent. Firstly, there is
the question of the generation of so-called anti-
sense transcripts. It is well known that many genes
are transcribed in both directions producing anti-
sense transcripts that appear to play an important
regulatory role [28]. However, there are many
examples where these anti-sense transcripts also
contain ORFs and are indeed transcribed
[4,20,23,24,25]. These thus should be considered
for all intents and purposes distinct genes that
would be difﬁcult ever to predict without transcript,
and eventually, protein analysis. In addition there
are intriguing examples of distinct genes being
placed within the introns of other genes
[15,16,19,27]. Again, this is a very difﬁcult situation
to predict without transcript data.
We are in the process of systematically closing
EST clusters to generate full-length transcript
sequences by making predictions from the genome
mapping of the ESTs followed by RT-PCR experi-
mentation. These is a powerful approach that
permits the examination of the genome piece by
piece and does not require the essentially chance
generation of a full-length transcript from a cDNA
library to conﬁrm the structure of a gene. In the
process of leading up to this project we have
already compared the gene annotation on chromo-
some 22 with our own prediction of transcribed
regions based on ORESTES sequences that have
been generated in the FAPESP/LICR-Human
Cancer Genome Project being currently concluded
in Brazil [26]. This project has generated in excess of
one-million human ESTs from the central regions
of expressed human genes. When we mapped only
those that correspond to human chromosome 22
from amongst our ﬁrst 250 000 sequences we were
able to identify based on stringent criteria a further
219 regions not described in the original annota-
tion. We believe, but have not yet established, that
these may correspond to more than 100 novel genes
on this chromosome alone [26].
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Although we now have a draft human genome
sequence and although the expressed gene content
of the human genome is of fundamental interest
and has attracted intense investigation, we are far
from knowing what the gene content of the human
genome is. It is possible that indeed we are only at
the very beginning of our deﬁnition of this ‘periodic
table’ of the human body. Any conclusions con-
cerning our transcriptome or indeed proteome are
very premature. This is not only due to the huge
variety of transcripts that are generated from the
genome due to alternative splicing and poly-
adenylation but also because we have yet to identify
the genes themselves to any level of certainty.
Although there is much talk of the proteome being
the next step, it might be foolhardy to venture too
far into this world without ﬁrst establishing a very
ﬁrm foothold in that of the transcriptome ﬁrst.
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